Fabien, S., Olivier, M., Khaldoun, G., Vivian, V., Lynda, A., Laurissa, O., . . . Filomena, C. (2014). CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C after Liver Transplantation. BioMed Research International, 2014, 1. https://doi.org/10.1155/2014/290878
Chicago Style (17th ed.) CitationFabien, Stenard, et al. "CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C After Liver Transplantation." BioMed Research International 2014 (2014): 1. https://doi.org/10.1155/2014/290878.
MLA (9th ed.) CitationFabien, Stenard, et al. "CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C After Liver Transplantation." BioMed Research International, vol. 2014, 2014, p. 1, https://doi.org/10.1155/2014/290878.